Showcasing AI and medicine-engineering innovations at BIO International Convention 2025
Other Articles
Ten cutting-edge innovations and translational research projects from PolyU across the fields of artificial intelligence (AI) and medicine-engineering were featured at the BIO International Convention 2025 (BIO 2025), held in Boston, USA. This showcase highlighted the University’s interdisciplinary excellence and its leading position in medical and health research to global industry leaders.
BIO 2025 is recognised as the world’s largest biotechnology convention, encompassing all key aspects of the biotechnology ecosystem, including research and development, clinical trials, manufacturing, investment, business development, and commercialisation. This year, the event attracted over 20,000 industry leaders and professionals from about 70 countries and regions.
During the event, projects showcased by PolyU revealed innovations in drug discovery, medical devices and diagnostics, biomedical engineering, rehabilitation technologies, optometry and food science. The participating research teams also engaged in business forums and thematic discussions to cultivate meaningful connections, forge strategic partnerships and explore new avenues for collaboration with global industry leaders.
One of the key participants was Professor Ma Cong, Associate Professor of the Department of Applied Biology and Chemical Technology, who presented his latest breakthrough in antibiotic therapeutics. He has led a research team to discover a first-in-class antimicrobial drug with a unique mechanism of action to tackle antimicrobial resistance. His innovative approach focuses on disrupting protein–protein interactions (PPIs) within the bacterial transcription complex, offering hope for the development of new antimicrobial agents.
Ten PolyU innovations exhibited at BIO 2025 included:
Research project | Project leader |
PocNova™: Ultra-Fast Nucleic Acid Testing System | Professor Thomas Lee, Associate Professor of the Department of Biomedical Engineering |
Hybrid Robotic IoT for Telerehabilitation after Stroke | Professor Hu Xiaoling, Associate Professor of the Department of Biomedical Engineering |
Vcare: Vision Training VR Device | Ir Dr Tang Yu-ming, Senior Lecturer of the Department of Industrial and Systems Engineering |
Innovative Hormones for the Treatment of Diabetes and Related Metabolic Complications | Professor Wong Chi-ming, Associate Professor of the Department of Health Technology and Informatics |
HAND-HEART: An AI-Based Hand Hygiene Augmented Reality Tool | Professor Yang Lin, Associate Professor of the School of Nursing |
ABarginase: First-in-class Drug for Treatment of Multiple Obesity-related Metabolic Diseases | Professor Thomas Leung Yun-chung, Professor of the Department of Applied Biology and Chemical Technology |
First-in-Class Antibiotic Therapeutics | Professor Ma Cong, Associate Professor of the Department of Applied Biology and Chemical Technology |
Novel Nutraceuticals for Neurodegenerative Diseases | Professor Simon Lee Ming-yuen, Chair Professor of Biomedical Sciences of the Department of Food Science and Nutrition |
AkkMore™: a Fungus- and Plant-based Supplement against Obesity and Prediabetes | Dr Gail Chang Jinhui, Research Assistant Professor of the Department of Food Science and Nutrition |
Safe & Eco-friendly Antimicrobial Materials | Dr Gavin Zhang, Research Fellow of the School of Fashion and Textiles |
The ten cutting-edge innovations highlighted PolyU’s interdisciplinary excellence and its leading position in medical and health research at BIO 2025.
